Radiation myelitis following allogeneic stem cell transplantation and consolidation radiotherapy for non-Hodgkin's lymphoma

Bone Marrow Transplantation

Volumn 26, Issue 12, 2000, Pages 1355-1359

  Schwartz, D L ^a,b   Schechter, G P ^c,d   Seltzer, S ^c,d   Chauncey, T R ^a,b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Consolidation radio therapy; Lymphoma; Radiation myelitis; Spinal cord toxicity; Total body irradation; Transplantation

Indexed keywords

ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DOXORUBICIN; FAMCICLOVIR; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISONE; RECOMBINANT ERYTHROPOIETIN; STEROID; VINCRISTINE;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE PREDISPOSITION; DISEASE SEVERITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MALE; MEDIASTINUM; MUSCLE WEAKNESS; MYELITIS; NEUROTOXICITY; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARALYSIS; PARESTHESIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION FIELD; RADIATION INJURY; SENSORY DYSFUNCTION; SPINAL CORD DISEASE; WHOLE BODY RADIATION;

ADULT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MYELITIS; SPINAL CORD; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 0034487669     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702705     Document Type: Article

References (27)

1. Late effects of cancer treatment: Radiation and drug toxicity
2. Response of the central nervous system to boron neutron capture irradiation: Evaluation using rat spinal cord model
3. Radiation tolerance of the spinal cord
4. Radiation tolerance of the cervical spinal cord
5. Invited review: Permanent radiation myelopathy
6. Radiation response of the central nervous system
7. The incidence of myelitis after irradiation of the cervical spinal cord
8. Retreatment tolerance of the spinal cord
9. Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation
10. EPOCH chemotherapy: Toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma
11. Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: A phase I/II trial
12. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor
13. Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: A prospective, randomized trial
14. Autologous marrow transplantation for malignant lymphoma: A report of 101 cases from Seattle
15. Involved field radiation therapy for Hodgkin's disease autologous bone marrow transplantation regimens
16. High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: The impact of involved field radiotherapy on patterns of failure and survival
17. Involved field radiation post autologous stem cell transplantation in lymphoma patients is associated with major haematological toxicities
18. Myelopathies in the cancer patient: Incidence, presentation, diagnosis and management
19. Radiation myelopathy following transplantation and radiotherapy for non-Hodgkin's lymphoma
20. Continuous, hyperfractionated, accelerated radiotherapy (CHART): An interim report upon late morbidity
21. Myelopathy following hyperfractionated accelerated radiotherapy for anaplastic thyroid carcinoma
22. Neurologic sequelae of methotrexate and ionizing radiation: A new classification
23. Total body irradiation: A neuropsychological risk factor in pediatric bone marrow transplant recipients
24. Central nervous system workshop
25. Excessive spinal cord toxicity from intensive central nervous system-directed therapies
26. The risks of central nervous system relapse and leukoencephalopathy in patients receiving marrow transplants for acute leukemia